The emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the market, which is driven by growing healthcare infrastructure, vast population pool, rising demand for quality care, and the increasing healthcare spending. The global nurse …
According to research report the global Genome Engineering Market is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022. Lucrative North America markets to offer significant growth opportunities …
Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. The ligation devices market is projected to reach …
Growth in this market is largely driven by the rising global prevalence of cancer, growing awareness regarding cell-based therapies, and increasing government funding cell-based studies. The cell expansion market is projected to reach USD 26.0 billion by 2024 from USD 12.7 billion in 2019, at …
The global live cell encapsulation market was valued at USD 250 million in 2018 and is projected to reach USD 303 million by 2024, at a CAGR of 3.2% during the forecast period. The rising number of target patient population, increasing public-private investments to support …
Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption amongst patients. The global injection pen market is expected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017, at a …
According to the new market research report Single-use Bioreactors Market is expected to grow at a CAGR of 21.9% from 2017 to 2022, to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017. The single-use bioreactors market is segmented on the basis of product type, …
The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% from 2019 to 2024. Market growth is largely driven by factors such as the rising incidence of hospital-acquired infections (HAIs), growth …
The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase …
According to research report the global in vitro toxicology testing market is projected to reach USD 8.74 billion by 2022 from USD 6.34 billion in 2017, at a CAGR of 6.6% during the forecast period. Factors such as opposition to animal testing, advent new and promising technologies, …
The growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected …
The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. The respiratory drug …
Increasing prevalence of diseases, demand for liquid biopsy, growing demand for blood components, and increasing number of surgeries and accidental cases are the factors driving the growth of the market. Blood collection is the process of acquiring blood samples from the donor for performing laboratory …
The CRISPR technology market is driven by various factors such as increasing funding and private investments and the growing adoption of CRISPR technology. However, the presence of alternate technologies can hinder the growth of the market. What the Market Looks Like? The CRISPR technology market …